Characteristics of subjective cognitive decline associated with amyloid positivity.

Détails

Ressource 1Télécharger: 34877782_BIB_D70F024AB648.pdf (1680.13 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
ID Serval
serval:BIB_D70F024AB648
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Characteristics of subjective cognitive decline associated with amyloid positivity.
Périodique
Alzheimer's & dementia
Auteur⸱e⸱s
Janssen O., Jansen W.J., Vos SJB, Boada M., Parnetti L., Gabryelewicz T., Fladby T., Molinuevo J.L., Villeneuve S., Hort J., Epelbaum S., Lleó A., Engelborghs S., van der Flier W.M., Landau S., Popp J., Wallin A., Scheltens P., Rikkert M.O., Snyder P.J., Rowe C., Chételat G., Ruíz A., Marquié M., Chipi E., Wolfsgruber S., Heneka M., Boecker H., Peters O., Jarholm J., Rami L., Tort-Merino A., Binette A.P., Poirier J., Rosa-Neto P., Cerman J., Dubois B., Teichmann M., Alcolea D., Fortea J., Sánchez-Saudinós M.B., Ebenau J., Pocnet C., Eckerström M., Thompson L., Villemagne V., Buckley R., Burnham S., Delarue M., Freund-Levi Y., Wallin Å.K., Ramakers I., Tsolaki M., Soininen H., Hampel H., Spiru L., Tijms B., Ossenkoppele R., Verhey FRJ, Jessen F., Visser P.J.
Collaborateur⸱rice⸱s
Alzheimer's Disease Neuroimaging Initiative, FACEHBI study group, PREVENT-AD research group
ISSN
1552-5279 (Electronic)
ISSN-L
1552-5260
Statut éditorial
Publié
Date de publication
10/2022
Peer-reviewed
Oui
Volume
18
Numéro
10
Pages
1832-1845
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, N.I.H., Extramural
Publication Status: ppublish
Résumé
The evidence for characteristics of persons with subjective cognitive decline (SCD) associated with amyloid positivity is limited.
In 1640 persons with SCD from 20 Amyloid Biomarker Study cohort, we investigated the associations of SCD-specific characteristics (informant confirmation, domain-specific complaints, concerns, feelings of worse performance) demographics, setting, apolipoprotein E gene (APOE) ε4 carriership, and neuropsychiatric symptoms with amyloid positivity.
Between cohorts, amyloid positivity in 70-year-olds varied from 10% to 76%. Only older age, clinical setting, and APOE ε4 carriership showed univariate associations with increased amyloid positivity. After adjusting for these, lower education was also associated with increased amyloid positivity. Only within a research setting, informant-confirmed complaints, memory complaints, attention/concentration complaints, and no depressive symptoms were associated with increased amyloid positivity. Feelings of worse performance were associated with less amyloid positivity at younger ages and more at older ages.
Next to age, setting, and APOE ε4 carriership, SCD-specific characteristics may facilitate the identification of amyloid-positive individuals.
Mots-clé
Humans, Amyloid, Amyloidogenic Proteins, Amyloidosis, Apolipoprotein E4/genetics, Biomarkers, Brain/metabolism, Cognitive Dysfunction/genetics, Cognitive Dysfunction/psychology, Positron-Emission Tomography, Alzheimer's disease, amyloid, cerebrospinal fluid, positron emission tomography, subjective cognitive decline
Pubmed
Web of science
Open Access
Oui
Création de la notice
11/12/2021 11:56
Dernière modification de la notice
25/01/2024 7:45
Données d'usage